436
edits
Changes
→Common Alteration Types
A number of other gene fusion partners have been identified with ABL1 and linked to other hematological cancers, but at a much smaller prevalence than BCR-ABL1.
A number of other gene fusion partners have been identified with ABL1 and linked to other hematological cancers, but at a much smaller prevalence than BCR-ABL1.
BCR-JAK2
A small number of individual patients have been described with a BCR-JAK2 (Janus Kinase 2) fusion gene leading to Chronic myeloid leukemia (CML) and other hematological neoplasms, but this fusion gene appears to be rare (12, 13, 14).
BCR-FGFR1
BCR-FGFR1